Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia

被引：0
|
作者：
Jiang Cao
Hai Cheng
Ming Shi
Gang Wang
Wei Chen
Kunming Qi
Huizhong Li
Jianlin Qiao
Jing Zhao
Qingyun Wu
Lingyu Zeng
Guangjun Jing
Junnian Zheng
Kailin Xu
机构：
[1] The Affiliated Hospital of Xuzhou Medical University,Department of Hematology
[2] Xuzhou Medical University,Cancer Institute
[3] Jiangsu Bone Marrow Stem Cell Institute,Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute
[4] iCARTAB biomedical co. Ltd,Center of Clinical Oncology
[5] Xuzhou Medical University,undefined
[6] The Affiliated Hospital of Xuzhou Medical University,undefined
来源：
Leukemia | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2751 / 2753
页数：2
相关论文
共 50 条
  • [41] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang, Xian
    Li, Jing-Jing
    Lu, Pei-Hua
    CHINESE MEDICAL JOURNAL, 2020, 133 (04) : 474 - 482
  • [42] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    An, Furun
    Wang, Huiping
    Liu, Zhenyun
    Wu, Fan
    Zhang, Jiakui
    Tao, Qianshan
    Li, Yingwei
    Shen, Yuanyuan
    Ruan, Yanjie
    Zhang, Qing
    Pan, Ying
    Zhu, Weiwei
    Qin, Hui
    Wang, Yansheng
    Fu, Yongling
    Feng, Zhenqing
    Zhai, Zhimin
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang Xian
    Li Jing-Jing
    Lu Pei-Hua
    中华医学杂志英文版, 2020, 133 (04) : 474 - 482
  • [44] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    Furun An
    Huiping Wang
    Zhenyun Liu
    Fan Wu
    Jiakui Zhang
    Qianshan Tao
    Yingwei Li
    Yuanyuan Shen
    Yanjie Ruan
    Qing Zhang
    Ying Pan
    Weiwei Zhu
    Hui Qin
    Yansheng Wang
    Yongling Fu
    Zhenqing Feng
    Zhimin Zhai
    Nature Communications, 11
  • [45] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
    Curran, Kevin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [46] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
  • [47] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
  • [48] Impact of retronectin-mediated T cell activation on CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, S.
    Hoffmann, J. -M
    Schubert, M. -L
    Wang, L.
    Wang, S.
    Gong, W.
    Neuber, B.
    Gern, U.
    Schmitt, A.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Sellner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 86 - 86
  • [49] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Li, Amanda M.
    Hucks, George E.
    Dinofia, Amanda M.
    Seif, Alix E.
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Fasano, Christina
    McBride, Beth
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Porter, David L.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD, 2018, 132
  • [50] Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: history, current situation, and future
    Muller, Bradley J.
    Inaba, Hiroto
    TRANSLATIONAL PEDIATRICS, 2023, 12 (10) : 1900 - 1907
12345